< Back to latest news & events

UPC

UK to Ratify UPC Agreement

November 2016

The UK government has confirmed it is proceeding with preparations to ratify the Unified Patent Court Agreement. Despite the vote to Brexit, the UK government has announced it will continue with preparations for ratification over the coming months. This has come as a surprise to many who expected Brexit to be a barrier to ratification by the UK.

The Government’s announcement confirmed that the UK will be working with the UPC Preparatory Committee to bring the UPC into operation as soon as possible. The announcement confirming the UK’s intention to ratify stated that “the UPC itself is not an EU institution, it is an international patent court and the judiciary appointed include UK judges”. While this is true, it does not address the fact that at present, participants must be members of the EU and that the Court will be subject to the Court of Justice of the European Union (CJEU). In respect of references to the CJEU, it is not clear how the Government will resolve this issue in light of the Prime Minister’s first speech on Brexit where she said: “Our laws will be made not in Brussels but in Westminster. The judges interpreting those laws will sit not in Luxembourg but in courts in this country. The authority of EU law in Britain will end”.

However, now it is clear that the UK plans to go ahead with ratification, any uncertainties need to be put aside. With German ratification also expected imminently, the UPC could be up and running by early autumn 2017. Patentees will need to act quickly to make preparations for understanding and navigating both a new unitary patent regime covering many EU member states and also for a new supranational court; the UPC. The UPC will have an entirely new set of procedural rules and jurisdiction over unitary patents (UPs) and European patents (EPs) that have not been opted-out.

The UPC Preparatory Committee has been continuing its work even during the time of uncertainty, so the Sunrise period for opting-out your patents could begin any time in 2017, with the UPC opening for business before the end of 2017.

Why UK ratification of the UPC Agreement matters

The new system comes into effect when the UPC Agreement is ratifed by 13 participating countries which must include the three EU Member States in which the most European patents had effect in 2012 (the year before the Agreement was signed (Article 89)). Now the UK is preparing to ratify, there is no doubt these three countries are the UK, Germany and France.

By November 2016, a total of 11 Member States had ratified the UPC Agreement: Austria, Belgium, Bulgaria, Denmark, Finland, France, Luxembourg, Malta, the Netherlands, Portugal and Sweden. Italy, Ireland, Lithuania, Slovenia, Germany and the UK are taking steps or moving through the legislative process to ratify the UPC Agreement.

We estimate that the new timetable for ratification will be such that the UK and Germany will ratify, then officially “deposit” their ratification by spring 2017, paving the way for the UPC to open for business by autumn 2017, and at the same time, UPs will become available for patent applicants via the European Patent Office. The participating EU member states have also agreed a Protocol to allow the Registry to open before launch so that patentees can register any opt-out, which will then take effect on the first day that the Court is open.

What steps should I take now?

Unitary Patents will always be subject to the jurisdiction of the new UPC, and granted EPs will be subject to the jurisdiction of the UPC as well as the relevant national courts, unless they are opted out of the UPC. Whether patentees want their granted and pending EPs to be subject to the jurisdiction of the UPC will depend on many factors; there is no one size fits all. Patentees   shouldn’t assume that opting out will be the best option: there may be advantages to keeping at least some of your patents within the jurisdiction of the UPC. As details of the Rules and  Procedures for the UPC system have crystallised, many patentees are considering a nuanced approach to managing the opt-out (or remaining subject to the UPC’s jurisdiction) for their patent portfolio.

With UK ratification of the UPC Agreement now on the horizon, it is vital to prepare your existing patent portfolio for the new patent litigation landscape in Europe. If you have not already done so, you need to start considering your strategy as to whether you want to opt-out your EPs from the jurisdiction of the UPC. Your review should consider the following issues:

  • the strength of the relevant patents;
  • the value of the technology covered by each patent or patent family to the business in the relevant jurisdiction;
  • how your various patents interact to protect your commercial products;
  • the likelihood in your industry that a third party will consider a central attack on the validity of your patents attractive;
  • for patents that are jointly-owned or licensed into or out of the business — who has the right to exercise the opt-out of the EPs (and any associated SPC)?

This exercise needs to be done sufficiently ahead of the launch of the UPC in order to give you time to execute any opt-out before the UPC opens for business. An opt-out is only effective once it is entered on the Register.

If you would like to discuss strategy portfolio review, HGF can provide you with assistance and guidance on formulating and implementing your company’s plan for the opening of the UPC. Should you have any further questions about the UPC and opt-out please contact our dedicated UPC team at [email protected] or contact your usual attorney to discuss these issues further.

Disclaimer

This briefing note is for information and discussion only, and should not be taken as a source of legal advice. If you require IP-related advice please contact us at [email protected] or consult a suitably qualified legal representative.

Latest updates

The EPO Looks at the Morality and Patentability of Therapeutics Derived from Traditional Knowledge

This case (T2510/181) heard before the Technical Boards of Appeal at the EPO in May 2024 relates to the morality and novelty of substances of a natural origin. The invention …

Read article
Event - 7th November 2024

CIPSC Corporate IP Strategy Conference

HGF are proud to be platinum sponsors of the CIPSC event in Santa Clara, US. The CIPSC Unified Patents event will be held in Santa Clara, US on Thursday 7th …

Event details
Event - 7th November 2024

OUI Annual Networking Event

HGF are proud to be sponsoring the OUI Annual Networking Event in London on Thursday 7th November. This event will host key discussions around the impact of the Oxford’s Innovation …

Event details

Bite-sized MBA Course

HGF are proud to announce 14 of our colleagues have completed a bite-sized MBA and have now achieved a strategy consultation accreditation awarded from The University of East Anglia. The …

Read article
Event - 24th October 2024

CTA Demo Day

HGF is proud to be speaking at the Cancer Tech Accelerator Demo Day 2024. The Cancer Tech Accelerator Day 2024 will be held at HGF Limited, Leeds on Thursday 24th …

Event details

Two IPs In a Pod - Practical experiences and insights of using the UPC

Our Head of Law Rachel Fetches is speaking on the latest episode of the Charted Institute Of Patent Attorneys Two IPs In a Pod podcast and in this episode they …

Read article